Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245111 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Trauma Patients
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT04245111: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04245111 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04245111 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This will be a prospective observational trial to better understand the range and variation associated with bone/soft tissue perfusion in fracture patients and examine the relationship between perfusion, measured using quantitative Indocyanine green (ICG) fluorescence and complications such as surgical site infection (SSI), persistent SSI, and fracture nonunion.
Primary Outcome
As this is a pilot and feasibility study, the outcome measure is the percent of patients that successfully complete the protocol.
Interventions
- OTHER Immunofluorescence Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2022-11-18 |
What the finished NCT04245111 record still lists
NCT04245111 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Immunofluorescence Imaging is the first listed.
NCT04245111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04245111 about?
NCT04245111 is a clinical study titled "ICG Fluorescence Imaging in Trauma Patients". This will be a prospective observational trial to better understand the range and variation associated with bone/soft tissue perfusion in fracture patients and examine the relationship between perfusion, measured using quantitative Indocyanine green (ICG) fluorescence and complications such as surgi...
What is the current status of trial NCT04245111?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-05-16. Estimated completion is 2022-11-18.
What interventions are being tested in trial NCT04245111?
The interventions under investigation include: Immunofluorescence Imaging (OTHER).
Who is sponsoring clinical trial NCT04245111?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI